Scott A Koepsell
Overview
Explore the profile of Scott A Koepsell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renavikar P, Warkentin P, Williams S, Gundabolu K, Branson C, Koepsell S
Stem Cell Res Ther
. 2024 Aug;
15(1):251.
PMID: 39135194
Collection of hematopoietic progenitor cell products [HPC(A)] is deferred if the donor is symptomatic and tests positive for Covid-19. However, donor questionnaires are subjective and may miss minimally symptomatic donors....
2.
Koepsell S, Stolla M, Sedjo R, Carson J, Knudson M, Cook R, et al.
Transfusion
. 2024 Feb;
64(3):457-465.
PMID: 38314476
Background: The Mirasol® Pathogen Reduction Technology System was developed to reduce transfusion-transmitted diseases in platelet (PLT) products. Study Design And Methods: MiPLATE trial was a prospective, multicenter, controlled, randomized, non-inferiority...
3.
Bertrand B, Heim C, Koepsell S, Kielian T
J Leukoc Biol
. 2023 Dec;
115(4):620-632.
PMID: 38095415
Myeloid-derived suppressor cells (MDSCs) are pathologically activated immature myeloid cells with immunosuppressive activity that expand during chronic inflammation, such as cancer and prosthetic joint infection (PJI). Myeloid-derived suppressor cells can...
4.
Auen T, Renavikar P, Habib E, Koepsell S
J Clin Apher
. 2023 Jul;
38(6):764-769.
PMID: 37519096
Chronic lymphocytic leukemia (CLL) is a clonal mature B-cell neoplasm with a typically indolent clinical course. Though most clinicians follow these neoplasms through observation alone, an aggressive transformation to prolymphocytic...
5.
Koepsell S, Fitts E, Roback J
Transfusion
. 2022 Dec;
63(2):427-429.
PMID: 36519703
No abstract available.
6.
Williams S, Bobr A, Koepsell S
J Clin Apher
. 2022 Nov;
38(1):69-72.
PMID: 36345592
The prevalence of mental health disorders among apheresis patients is unknown. Patients with chronic conditions treated with apheresis in the outpatient setting often see their apheresis healthcare professionals more frequently...
7.
Asif S, Kesireddy M, Koepsell S, A Gonzalez-Castellon M, Gundabolu K, Baljevic M
Neurohospitalist
. 2022 Apr;
12(2):346-351.
PMID: 35419151
Thrombosis with Thrombocytopenia Syndrome (TTS) or Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) had been reported in patients receiving the Ad26.COV2.S vaccination (Johnson & Johnson [J&J]/Janssen) vaccine. They frequently presented with cerebral...
8.
Kanack A, Singh B, George G, Gundabolu K, Koepsell S, Abou-Ismail M, et al.
Am J Hematol
. 2022 Feb;
97(5):519-526.
PMID: 35132672
Rare cases of COVID-19 vaccinated individuals develop anti-platelet factor 4 (PF4) antibodies that cause thrombocytopenia and thrombotic complications, a syndrome referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT). Currently, information...
9.
Muir K, Kallam A, Koepsell S, Gundabolu K
N Engl J Med
. 2021 Apr;
384(20):1964-1965.
PMID: 33852795
No abstract available.
10.
Abdalhamid B, Bilder C, McCutchen E, Hinrichs S, Koepsell S, Iwen P
medRxiv
. 2020 Jun;
PMID: 32511649
Objectives To establish the optimal parameters for group testing of pooled specimens for the detection of SARS-CoV-2. Methods The most efficient pool size was determined to be 5 specimens using...